Eli Lilly’s Experimental Obesity Drug Shows Unprecedented Weight Loss in Patients
Eli Lilly’s experimental obesity drug, retatrutide, has shown impressive results in mid-stage clinical trials, with patients experiencing up to 24% weight loss after almost a year, the highest reduction seen in the field. The…
Continue Reading